Kairos Pharma (KAPA) Debt Ratio (2024)
Kairos Pharma's (KAPA) quarterly Debt Ratio came in at 0.16 in Q3 2024.
Powered by 
Analysis
Kairos Pharma (KAPA) Debt Ratio (2024) Analysis & Trends
Kairos Pharma (KAPA) has reported Debt Ratio for 1 consecutive years, with 0.16 the latest figure, recorded in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.85 Bn | 192.86 Bn | 7.24 Bn | 0.66 |
| 2 | Gilead Sciences | 180.09 Bn | 176.91 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 131.06 Bn | 123.21 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.82 Bn | 73.82 Bn | 3.93 Bn | 0.05 |
| 5 | Argenx Se | 60.39 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.31 Bn | 49.17 Bn | 52.00 Mn | 0.05 |
| 7 | Alnylam Pharmaceuticals | 33.13 Bn | 29.82 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.90 Bn | 30.62 Bn | 1.96 Bn | 0.25 |
| 9 | Roivant Sciences | 29.23 Bn | 29.23 Bn | 1.16 Mn | - |
| 10 | Kairos Pharma | 31.14 Mn | 25.81 Mn | - | - |